68 filings
Page 2 of 4
8-K
35tod9k28bp5sm6up
21 Nov 22
Regulation FD Disclosure
6:16pm
8-K
uqbsfethbn1t
9 Nov 22
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:28am
8-K
eek1cwhstl8ks7n jpi
19 Aug 22
Departure of Directors or Certain Officers
9:15am
8-K
13raz6r
5 Aug 22
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:12pm
8-K
2fs4ujl
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:28pm
8-K
jxmrp 4br
9 Jun 22
Entry into a Material Definitive Agreement
4:34pm
8-K
tsn1mmf5 oyznnk
5 May 22
Arvinas Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
tx4bp4qsjtlsxul
28 Feb 22
Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:56pm
8-K
8zpw 2kctu94hn9
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
4rid9fi7pxc7s
15 Feb 22
Arvinas Announces New Data from Completed Phase 1 Dose Escalation and Ongoing Phase 2
12:00am
8-K
5jq40w3yb9dguf js
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
qrxh3k 9f5y48wiuo
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
fk89igilxopgpqoe i2
28 Sep 21
Regulation FD Disclosure
7:30am
8-K
d2ed15ck3mswj
13 Sep 21
Other Events
4:09pm
8-K
1xqay9u1umac9zyz35
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
xdrnk0ak
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
2j9g0wov75o 1xe
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
8se r8m08tmgu8u
9 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
4rcggo5oyev
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
p15s9t 8zqp0byw66251
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm